SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-000431
Filing Date
2022-01-05
Accepted
2022-01-05 17:00:51
Documents
14
Period of Report
2022-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K FOR ROGERIO VIVALDI APPOINTMENT crnx-8k_20220103.htm   iXBRL 8-K 40160
2 EX-99.1 crnx-ex991_7.htm EX-99.1 15044
3 GRAPHIC gwgodhcyhghv000001.jpg GRAPHIC 20636
  Complete submission text file 0001564590-22-000431.txt   224165

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA crnx-20220103.xsd EX-101.SCH 5933
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20220103_lab.xml EX-101.LAB 20485
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20220103_pre.xml EX-101.PRE 12746
8 EXTRACTED XBRL INSTANCE DOCUMENT crnx-8k_20220103_htm.xml XML 3691
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 22512052
SIC: 2834 Pharmaceutical Preparations